Reiff A - Search Results

1

Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment.

Reiff A. Reiff A. Biol Ther. 2012 Feb 1;2(1):1. doi: 10.1007/s13554-012-0001-6. eCollection 2012. Biol Ther. 2012. PMID: 24392296 Free PMC article. Review.

2

Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis.

Marzan KA, Reiff AO. Marzan KA, et al. Expert Rev Clin Immunol. 2008 Sep;4(5):549-58. doi: 10.1586/1744666X.4.5.549. Expert Rev Clin Immunol. 2008. PMID: 20476957

3

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.

Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W. Hong SD, et al. Among authors: reiff a. Arthritis Rheum. 2009 Nov;60(11):3400-9. doi: 10.1002/art.24902. Arthritis Rheum. 2009. PMID: 19877053 Free article.

4

Developments in the treatment of juvenile arthritis.

Reiff AO. Reiff AO. Expert Opin Pharmacother. 2004 Jul;5(7):1485-96. doi: 10.1517/14656566.5.7.1485. Expert Opin Pharmacother. 2004. PMID: 15212599 Review.

5

The use of anakinra in juvenile arthritis.

Reiff A. Reiff A. Curr Rheumatol Rep. 2005 Dec;7(6):434-40. doi: 10.1007/s11926-005-0047-2. Curr Rheumatol Rep. 2005. PMID: 16303102 Review.

6

Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.

Chang CY, Meyer RM, Reiff AO. Chang CY, et al. Arthritis Care Res (Hoboken). 2015 May;67(5):658-66. doi: 10.1002/acr.22477. Arthritis Care Res (Hoboken). 2015. PMID: 25220674 Free article.

7

Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.

Reyhan I, Zhukov OS, Lagier RJ, Bridgforth RF, Williams GJ, Popov JM, Naides SJ, Reiff A. Reyhan I, et al. Among authors: reiff a. Pediatr Rheumatol Online J. 2021 Feb 16;19(1):14. doi: 10.1186/s12969-021-00502-8. Pediatr Rheumatol Online J. 2021. PMID: 33593401 Free PMC article.

8

High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.

Reiff A, Shaham B, Wood BP, Bernstein BH, Stanley P, Szer IS. Reiff A, et al. Clin Exp Rheumatol. 1995 Jan-Feb;13(1):113-8. Clin Exp Rheumatol. 1995. PMID: 7774090 Clinical Trial.

9

Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.

Lovell DJ, Brunner HI, Reiff AO, Jung L, Jarosova K, Němcová D, Mouy R, Sandborg C, Bohnsack JF, Elewaut D, Gabriel C, Higgins G, Kone-Paut I, Jones OY, Vargová V, Chalom E, Wouters C, Lagunes I, Song Y, Martini A, Ruperto N. Lovell DJ, et al. Among authors: reiff ao. RMD Open. 2020 Jul;6(2):e001208. doi: 10.1136/rmdopen-2020-001208. RMD Open. 2020. PMID: 32665432 Free PMC article.

10

Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis.

Reiff A, Shaham B, Weinberg KI, Crooks GM, Parkman R. Reiff A, et al. J Clin Immunol. 2011 Aug;31(4):615-22. doi: 10.1007/s10875-011-9533-7. Epub 2011 May 4. J Clin Immunol. 2011. PMID: 21541793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page